CLOSED - Global Compensation & Benefit Manager
European Search Company
THE POSITION IS CLOSED AND YOU CANNOT APPLY
Are you our new C&B Manager who can ensure compensation and benefits best practice and thereby help us attract and retain our talent? In this role, you get to develop and implement global compensation and benefit frameworks, using your experience in a company where we work to save and enhance lives.
Xellia Pharmaceuticals is a leading developer, manufacturer and supplier of life-saving anti-infectives. We excel within innovative product development to deliver high quality products. Currently, we are expanding and optimizing across the business. This provides a unique opportunity for you to create impact and contribute to shaping Xellia Pharmaceuticals for the future.
An influential role is waiting for you
You will be our new go-to compensation and benefits manager with a global outlook. This includes Danish operational compensation and benefits responsibility and given your international experience and know-how, you will also be working on building a global set-up with aligned processes and value-adding services across all 12 locations and 10 countries. You will work with multiple international stakeholders to identify and implement best practice. Your job will entail:
- Handling salary regulation, bonus processes, supplier contact etc. – all the classic compensation and benefits tasks.
- Being the global owner on Mercer’s Career Framework.
- Carrying out benchmark and market analyses to ensure that our rewards and benefits are competitive.
- Providing your specialist expertise to business critical projects in our global HR team.
We add value – to our work and our environment
Your 25 colleagues are ready to welcome you into our global HR department. You will be based in Copenhagen with 10 of your colleagues who are all HR specialists with several years of experience. We are proud of having created an environment with a feel-good atmosphere where we join forces to solve our tasks and add value. We work together across countries, and we are looking forward to receiving your specialist knowledge as our new colleague.
Experienced compensation and benefits specialist
As a person, it is important that you are outgoing and thereby able to facilitate the dialogues and discussions with different stakeholders and argument for your choices and recommendations. Moreover, you will need good business acumen and solid analytical skills allowing you to crunch numbers, analyse data and calculate consequences.
- You most likely have a degree within HR, finance or similar.
- You have 5+ years of experience within compensation and benefits from an international company.
- You are an experienced specialist, familiar with different types of incentives and benefit schemes as well as compensation cycle management.
- It is a plus if you have knowledge of Mercer’s Career Framework.
- You speak and write Danish and English effortlessly.
Additional information and how to apply
If you have any questions regarding the position, please contact Brian Ranvits, CEO at European Search Company who carries out this recruitment. Brian Ranvits +45 2048 0548 [email protected]
Please apply directly by clicking the link at the apply button.
Xellia Pharmaceuticals is owned by Novo Holding A/S and is a specialty pharmaceutical company leading in the development, manufacture and supply of anti-infective treatments. Headquartered in Copenhagen, Denmark, Xellia has global facilities in Europe, North America, and Asia, currently employing over 1700 people. With over 100 years of industry experience in developing last resort treatments for infectious diseases, Xellia is focused on the supply of products which not only save lives, but also improve and enhance patients’ quality of life. Together with us, you can help lead the fight against bacterial infections.
Read more about Xellia Pharmaceuticals here
Department: Xellia PharmaceuticalsLocation: Frederiksberg Smallegade 2
Opslaget er indhentet automatisk fra virksomhedens jobsider og vises derfor kun som uddrag. Log ind for at se det fulde opslag eller gå videre til opslaget her: